Koyfin Home > Directory > Health Care > Revance Therapeutics > Dividiend yield (D/Y)

Revance Therapeutics Dividiend yield (D/Y) Chart (RVNC)

Revance Therapeutics annual/quarterly Dividiend yield (D/Y) from 2020 to 2020.
Other Valuation Metrics:
  • Revance Therapeutics Market Cap for the quarter ending March 03, 2018 was $1,131m a 29.36% increase of 332m year over year
  • Revance Therapeutics Price / Book for the quarter ending March 03, 2018 was 4.18 a -6.42% decrease of -0.27 year over year
  • Revance Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $850m a 27.67% increase of 235m year over year
View Chart On Koyfin